Viewing Study NCT06280105


Ignite Creation Date: 2025-12-25 @ 3:33 AM
Ignite Modification Date: 2025-12-26 @ 2:15 AM
Study NCT ID: NCT06280105
Status: RECRUITING
Last Update Posted: 2025-05-15
First Post: 2024-02-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Trial of Cadonilimab Plus Regorafenib in Patients With Hepatocellular Carcinoma Who Failed Camrelizumab Combined With Apatinib
Sponsor: Meng Chao Hepatobiliary Hospital of Fujian Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module